André Verwei, MSc, RA, joined Cristal Therapeutics as Chief Finance Officer in August 2019.
He started his career at PWC in Utrecht, the Netherlands.
André has held senior financial positions at various private and listed biotech companies including Senior VP Finance at ProQR, CFO at Amsterdam Molecular Therapeutics(now UniQure) and Director of International Finance at IsoTis. He has played an instrumental role during various corporate transactions as well as ProQR’s IPO on Nasdaq and Amsterdam Molecular Therapeutic’s IPO on Euronext Amsterdam.
André received his MSc business economics and his RA (Dutch CPA) from the Erasmus University in Rotterdam.